INS and type 2 diabetes mellitus: A recent study by Timmers et al. [20] randomised obese volunteers with well-controlled T2DM to placebo or resveratrol (150 mg/day) for 30 days to evaluate insulin sensitivity via hyperinsulinaemic-euglycaemic clamps.